Embolization Coils Market is expected to reach US$ 3,685.07 Million by 2031

Central Application Segment Drives Embolization Coils Market Growth

According to our new research study named "Embolization Coils Market Forecast to 2031 – Global Analysis – by Coils, Application, End User, and Geography," the market was valued at US$ 1,877.12 million in 2024 and is projected to reach US$ 3,685.07 million by 2031; it is expected to register a CAGR of 10.2% during 2025–2031. Rising prevalence of vascular disorders and aneurysms, burgeoning demand for minimally invasive procedures, and aging population drive the adoption of embolization coils. The development of next-generation embolic materials is projected to bring new embolization coils market trends in the coming years.

Embolization coils are precision-engineered metallic devices deployed within blood vessels to effectively halt abnormal blood flow, manage aneurysms, control hemorrhage, and reduce tumor vascularization through advanced, minimally invasive endovascular procedures. Increasing number of aneurysm cases, growing adoption of minimally invasive interventions, and technological advancements in coil materials and design are driving the global embolization coils market growth. Additionally, escalating healthcare expenditures and the widespread integration of image-guided interventions across hospitals and specialized endovascular centers worldwide are also contributing to the rising embolization coils market size.

Embolization Coils Market, by Region, 2024 (%)

Embolization Coils Market Analysis Based on Segmental Evaluation:
Based on coils, the embolization coils market is segmented into central application and peripheral application. The central application segment held a significant embolization coils market share in 2024, primarily driven by its focus on neurovascular interventions. These procedures encompass minimally invasive endovascular treatments for cerebral aneurysms and arteriovenous malformations (AVMs) within the brain and spinal cord. The segment utilizes detachable and pushable coils, deployed through endovascular catheters to occlude blood flow in targeted vessels, thereby mitigating the risk of rupture and hemorrhage.
Growth in this segment is strongly correlated with the rising prevalence of neurovascular disorders, largely attributed to the aging global population, which increases the incidence of aneurysms and AVMs. Additionally, risk factors such as hypertension, smoking, and diabetes have amplified the occurrence of ischemic strokes and hemorrhagic events, which have surged by 20% over the past decade.

Technological advancements further reinforce this trend. For instance, bioactive hydrogel-coated coils—such as Boston Scientific’s CEREPAK system—deliver superior packing density, achieving long-term occlusion rates of up to 95%, thereby minimizing the risk of recanalization. Moreover, innovations in imaging modalities, including digital subtraction angiography (DSA) and magnetic resonance angiography (MRA), enable precise coil placement, elevating procedural success rates from 80% to over 90%.

The geographical scope of the embolization coils market report encompasses an assessment of the market performance in North America, Europe, the Asia Pacific, South America, Central America, the Middle East, and Africa. North America dominated the embolization coils market share in 2024. The demand for embolization coils has surged significantly, driven by the rising prevalence of neurovascular disorders such as aneurysms and the escalating global cancer burden, both of which necessitate minimally invasive embolization procedures. Adoption of the technology continues to expand as innovations in coil materials, deliverability, and radiopacity enhance procedural success rates, thereby boosting the embolization coils market growth.

Furthermore, regions with a high concentration of leading medical device manufacturers benefit from faster product availability and sustained competitive advancements. Favorable reimbursement frameworks and robust healthcare spending are also fostering increased utilization of embolization procedures across hospitals and ambulatory surgical centers. The growing preference for minimally invasive techniques—attributed to shorter recovery times and reduced complication risks—is driving a clinical shift from conventional surgery toward embolization. Recent developments in 2025 have further catalyzed coil adoption:

• October 2025: Penumbra launched the SwiftSET Neuro Embolization Coil, engineered for superior precision in complex neurovascular anatomies. Its adaptive framing technology reduces procedure time while improving packing density.
• November 2025: The first US surgery utilizing a polymer-based biodegradable coil was performed in Delaware. This innovation accelerates endothelialization and significantly lowers long-term recanalization rates compared to traditional metal coils.
• June 2025: Embolization, Inc. secured FDA 510(k) clearance for its Nitinol Enhanced Device (NED)—a non-metallic coil solution designed to minimize post-operative imaging artifacts, enabling easier follow-up monitoring.

Therefore, the above-mentioned factors collectively support the growth of the global embolization coils market. 

NeuroSafe Medical Co. Ltd., Stryker Corp., Cook Medical Holdings LLC, Medtronic Plc, Terumo Corp., Boston Scientific Corp., Wallaby Medical, Penumbra Inc., Balt, and INVAMED are among the leading companies profiled in the embolization coils market report.

Based on coils, the embolization coils market is divided into central application and peripheral application. By application, the market is segmented into neurology, peripheral vascular disease, oncology, urology, and others. In terms of end user, the embolization coils market is classified into hospitals, ambulatory centers, and others. Geographically, the embolization coils market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com